Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark

NCT00240357 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00240357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Withdrawn
Start date
February 28, 2003
Completion date
Not reported
Enrollment
1,175
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia